{
  "symbol": "NAYA",
  "company_name": "Naya Biosciences Inc",
  "ir_website": "https://www.nayabiosciences.com/",
  "structured_data": [
    {
      "section_name": "Press Releases",
      "links": [
        {
          "title": "Naya Biosciences Announces New Product Launch for 2024",
          "url": "https://www.nayabiosciences.com/press-releases/naya-biosciences-announces-new-product-launch-for-2024",
          "content": "404\n\nPAGE NOT FOUND\n\nWe looked everywhere for this page. Are you sure the website URL is correct?Get in touch with the site owner.\n\nGo Back Home\n"
        },
        {
          "title": "Q1 2024 Financial Results",
          "url": "https://www.nayabiosciences.com/press-releases/q1-2024-financial-results",
          "content": "404\n\nPAGE NOT FOUND\n\nWe looked everywhere for this page. Are you sure the website URL is correct?Get in touch with the site owner.\n\nGo Back Home\n"
        }
      ]
    },
    {
      "section_name": "Financial Reports",
      "links": [
        {
          "title": "Annual Report 2024",
          "url": "https://www.nayabiosciences.com/financial-reports/annual-report-2024",
          "content": "404\n\nPAGE NOT FOUND\n\nWe looked everywhere for this page. Are you sure the website URL is correct?Get in touch with the site owner.\n\nGo Back Home\n"
        },
        {
          "title": "Q1 2024 Financial Report",
          "url": "https://www.nayabiosciences.com/financial-reports/q1-2024-financial-report",
          "content": "404\n\nPAGE NOT FOUND\n\nWe looked everywhere for this page. Are you sure the website URL is correct?Get in touch with the site owner.\n\nGo Back Home\n"
        }
      ]
    },
    {
      "section_name": "News Articles",
      "links": [
        {
          "title": "Naya Biosciences Featured in Biotechnology Monthly (2024 Edition)",
          "url": "https://www.nayabiosciences.com/news/naya-biosciences-featured-in-biotechnology-monthly-2024",
          "content": "top of page\n\n[![Screenshot_2023-10-03_at_9.50.39-removebg-preview.png](https://static.wixstatic.com/media/cef827_39c0bf993ec74339aa303c175d0dc99d~mv2.png/v1/fill/w_150,h_88,al_c,q_85,usm_0.66_1.00_0.01,enc_avif,quality_auto/Screenshot_2023-10-03_at_9_50_39-removebg-preview.png)](https://www.nayabiosciences.com)\n\n##### [NAYA Biosciences to Present Translational Insights to Support Phase I/IIa Clinical Trials for its GPC3-Targeting NK Engager Bispecific Antibody at the 2024 Annual Meeting of the Society for Immunotherapy of Cancer (SITC)](https://www.globenewswire.com/news-release/2024/10/31/2972674/0/en/NAYA-Biosciences-to-Present-Translational-Insights-to-Support-Phase-I-IIa-Clinical-Trials-for-its-GPC3-Targeting-NK-Engager-Bispecific-Antibody-at-the-2024-Annual-Meeting-of-the-So.html)\n\nOctober 31st, 2024\n\n##### [NAYA Biosciences Announces Initiation of Phase 1/2a Clinical Trial for its GPC3-targeted NK Engager Bispecific Antibody in Patients with Hepatocellular Carcinoma](https://bit.ly/3A10xwV)\n\nOctober 24th, 2024\n\n##### [INVO Bioscience Confirms Corporate Name Change and New Trading Symbol in Connection with Its Recent Merger with NAYA Biosciences](https://www.globenewswire.com/news-release/2024/10/21/2966236/0/en/INVO-Bioscience-Confirms-Corporate-Name-Change-and-New-Trading-Symbol-in-Connection-with-Its-Recent-Merger-with-NAYA-Biosciences.html)\n\nOctober 22nd, 2024\n\n##### [INVO Bioscience and NAYA Biosciences Close Merger, Combined Company to Operate as NAYA Biosciences (NASDAQ: NAYA)](https://www.globenewswire.com/news-release/2024/10/14/2962600/0/en/INVO-Bioscience-and-NAYA-Biosciences-Close-Merger-Combined-Company-to-Operate-as-NAYA-Biosciences-NASDAQ-NAYA.html)\n\nOctober 14th, 2024\n\n##### [Revolutionizing Healthcare: NAYA Biosciences' Vision for Oncology, Fertility & Regenerative Medicine (Jane King Interview With NAYA CEO Dr. Daniel Teper)](https://www.youtube.com/watch?v=V5dQcF74DmI)\n\nMarch 13th, 2024\n\n##### [How This New and Emerging Business Model Is Changing the Face of Biotech Today](https://www.nasdaq.com/articles/how-this-new-and-emerging-business-model-is-changing-the-face-of-biotech-today)\n\nFebruary 12th, 2024\n\n##### NAYA Biosciences To Acquire Clinical Stage Gene Therapy Program for Leber's Hereditary Optic Neuropathy (LHON)\n\nJanuary 23rd, 2024\n\n##### [INVO Bioscience Files S-4 Registration and Preliminary Joint Proxy Statements in Connection with Merger with NAYA Biosciences, NAYA Announces New Board Directors](https://www.globenewswire.com/en/news-release/2024/01/17/2810635/0/en/INVO-Bioscience-Files-S-4-Registration-and-Preliminary-Joint-Proxy-Statements-in-Connection-with-Merger-with-NAYA-Biosciences-NAYA-Announces-New-Board-Directors.html)\n\nJanuary 17th, 2024\n\n##### [NAYA Biosciences Announces Publication of New Data for its CD38-targeted Flex-NK™ Bispecific Antibody in the American Society of Hematology's Blood Journal](https://www.prnewswire.com/news-releases/naya-biosciences-announces-publication-of-new-data-for-its-cd38-targeted-flex-nk-bispecific-antibody-in-the-american-society-of-hematologys-blood-journal-302010970.html)\n\nDecember 11th, 2023\n\n##### [NAYA Biosciences and ONK Therapeutics Announce Research Partnership to Advance Combination Therapy of FLEX-NK™ Bispecific Antibodies and Optimally Engineered Off-the-Shelf Natural Killer Cell Therapies](https://www.prnewswire.com/news-releases/naya-biosciences-and-onk-therapeutics-announce-research-partnership-to-advance-combination-therapy-of-flex-nk-bispecific-antibodies-and-optimally-engineered-off-the-shelf-natural-killer-cell-therapies-302007057.html)\n\nDecember 6th, 2023\n\n##### [NAYA Biosciences and INVO Bioscience Announce Appointment of Dr. Peter Kash, Ed.D., MBA as Vice Chairman Following Closing of Their Merger](https://www.prnewswire.com/news-releases/naya-biosciences-and-invo-bioscience-announce-appointment-of-dr-peter-kash-edd-mba-as-vice-chairman-following-closing-of-their-pending-merger-301984271.html)\n\nNovember 10th, 2023\n\n##### [Free Registration Is Now Open For Tribe Public's CEO and Q&A Presentation Webinar Event \"Accelerating Biotech Value Creation\" Featuring NAYA Biosciences CEO Dr. Daniel Teper On Tuesday, October 31, 2023](https://www.prnewswire.com/news-releases/free-registration-is-now-open-for-tribe-publics-ceo-and-qa-presentation-webinar-event-accelerating-biotech-value-creation-featuring-naya-biosciences-ceo-dr-daniel-teper-on-tuesday-october-31-2023-301969766.html)\n\nOctober 27th, 2023\n\n##### [INVO Bioscience and NAYA Biosciences Announce Definitive Merger Agreement To Establish Expanded Publicly Traded Life Science Company](https://www.prnewswire.com/news-releases/invo-bioscience-and-naya-biosciences-announce-definitive-merger-agreement-to-establish-expanded-publicly-traded-life-science-company-301964066.html)\n\nOctober 23rd, 2023\n\n##### [INVO Closes Acquisition of Wisconsin Fertility Institute](https://www.prnewswire.com/news-releases/invo-closes-acquisition-of-wisconsin-fertility-institute-301898421.html)\n\nAugust 11th, 2023\n\n##### [INVO Receives 510(k) FDA Clearance for Expanded Use of the INVOcell Device](https://www.prnewswire.com/news-releases/invo-receives-510k-fda-clearance-for-expanded-use-of-the-invocell-device-301863927.html)\n\nJune 27th, 2023\n\n##### [INVO Congratulates Wisconsin Fertility Institute on Being Named One of America's Best Fertility Clinics by Newsweek](https://www.prnewswire.com/news-releases/invo-congratulates-wisconsin-fertility-institute-on-being-named-one-of-americas-best-fertility-clinics-by-newsweek-301790375.html)\n\nApri 5th, 2023\n\n##### [Dr. Sue Ellen Carpenter of INVO Bioscience's Atlanta-based INVO Center - Bloom Fertility - Named Top Doctor by Castle Connolly](https://www.prnewswire.com/news-releases/dr-sue-ellen-carpenter-of-invo-biosciences-atlanta-based-invo-center--bloom-fertility--named-top-doctor-by-castle-connolly-301631088.html)\n\nSeptember 22nd, 2022\n\n##### [New Birmingham INVO Center Offers Families an Affordable Advanced Fertility Treatment Solution to Help Combat Rising Costs](https://www.prnewswire.com/news-releases/new-birmingham-invo-center-offers-families-an-affordable-advanced-fertility-treatment-solution-to-help-combat-rising-costs-301499761.html)\n\nMarch 10th, 2022\n\n##### [INVO Bioscience Announces Official Opening of \"Bloom Fertility, an INVO Center\" in Atlanta](https://www.prnewswire.com/news-releases/invo-bioscience-announces-official-opening-of-bloom-fertility-an-invo-center-in-atlanta-301369987.html)\n\nSeptember 7th, 2021\n\n##### [INVO Bioscience Announces First Joint-Venture Grand Opening Scheduled for August 9, 2021 in Birmingham, Alabama](https://www.prnewswire.com/news-releases/invo-bioscience-announces-first-joint-venture-grand-opening-scheduled-for-august-9-2021-in-birmingham-alabama-301346364.html)\n\nAugust 2nd, 2021\n\n##### [INVO Bioscience Signs Joint Venture Agreement with Bloom Fertility to Open an INVOcell Fertility Clinic in Atlanta](https://www.prnewswire.com/news-releases/invo-bioscience-signs-joint-venture-agreement-with-bloom-fertility-to-open-an-invocell-fertility-clinic-in-atlanta-301322769.html)\n\nJune 30th, 2021\n\nbottom of page\n"
        }
      ]
    }
  ]
}